elb-139
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2006 (NCT00322803)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one
- elb139
- elb139
- elb139
- elb 139
- elb-139
- ls-191811
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00322803 | Phase 2 | May 1, 2006 | elbion, Maastricht University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| elbion | For profit | 1 | 1 | 1 | 2006 |
| Maastricht University | Academic/Hospital | 1 | 0 | 1 | 2006 |
2 organizations
Page 1 / 1